Despite the development of new ß-lactams and fluoroquinolones, aminoglycosides are still a very important class of antibacterials for the treatment of severe illness caused by a variety of pathogens, including Gram-negative bacteria, particularly if the pathogen has developed resistance to third-generation cephalosporins. (Introduction)
Auteur : Galimand M, Lambert T, Courvalin P
Eurosurveillance. European communicable disease quarterly, 2005, vol. 10, n°. 1-3, p. 59-60
